DE69615556T2 - Verfahren und apparat zum vorhersagen der präsenz von angeborenen und erworbenen unausgewogenheiten und therapeutischen zuständen - Google Patents

Verfahren und apparat zum vorhersagen der präsenz von angeborenen und erworbenen unausgewogenheiten und therapeutischen zuständen

Info

Publication number
DE69615556T2
DE69615556T2 DE69615556T DE69615556T DE69615556T2 DE 69615556 T2 DE69615556 T2 DE 69615556T2 DE 69615556 T DE69615556 T DE 69615556T DE 69615556 T DE69615556 T DE 69615556T DE 69615556 T2 DE69615556 T2 DE 69615556T2
Authority
DE
Germany
Prior art keywords
time
acquired
predicting
dependent measurement
congenital
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69615556T
Other languages
English (en)
Other versions
DE69615556D1 (de
Inventor
B Givens
Paul Braun
J Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69615556D1 publication Critical patent/DE69615556D1/de
Publication of DE69615556T2 publication Critical patent/DE69615556T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
DE69615556T 1995-06-07 1996-06-05 Verfahren und apparat zum vorhersagen der präsenz von angeborenen und erworbenen unausgewogenheiten und therapeutischen zuständen Expired - Fee Related DE69615556T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/477,839 US5708591A (en) 1995-02-14 1995-06-07 Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
PCT/US1996/008905 WO1996041291A1 (en) 1995-06-07 1996-06-05 A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions

Publications (2)

Publication Number Publication Date
DE69615556D1 DE69615556D1 (de) 2001-10-31
DE69615556T2 true DE69615556T2 (de) 2002-06-06

Family

ID=23897564

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69615556T Expired - Fee Related DE69615556T2 (de) 1995-06-07 1996-06-05 Verfahren und apparat zum vorhersagen der präsenz von angeborenen und erworbenen unausgewogenheiten und therapeutischen zuständen

Country Status (12)

Country Link
US (4) US5708591A (de)
EP (1) EP0834145B1 (de)
JP (1) JP3534415B2 (de)
KR (1) KR100462688B1 (de)
AT (1) ATE206226T1 (de)
AU (1) AU711998B2 (de)
CA (1) CA2221712C (de)
DE (1) DE69615556T2 (de)
DK (1) DK0834145T3 (de)
ES (1) ES2164888T3 (de)
PT (1) PT834145E (de)
WO (1) WO1996041291A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6321164B1 (en) * 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6016475A (en) * 1996-10-08 2000-01-18 The Regents Of The University Of Minnesota System, method, and article of manufacture for generating implicit ratings based on receiver operating curves
US6108493A (en) * 1996-10-08 2000-08-22 Regents Of The University Of Minnesota System, method, and article of manufacture for utilizing implicit ratings in collaborative filters
US5842199A (en) * 1996-10-18 1998-11-24 Regents Of The University Of Minnesota System, method and article of manufacture for using receiver operating curves to evaluate predictive utility
US6063028A (en) 1997-03-20 2000-05-16 Luciano; Joanne Sylvia Automated treatment selection method
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
DE19858278A1 (de) * 1998-12-17 2000-06-21 Dade Behring Marburg Gmbh Verfahren zum Lokalisieren von Defekten im Gerinnungssystem
WO2000046603A1 (en) * 1999-02-04 2000-08-10 Akzo Nobel N.V. A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
EP1522860A1 (de) * 1999-02-04 2005-04-13 bioMérieux, Inc. Verfahren und Vorrichtung zum Vorhersagen von haemostatischer Funktionsstörung in Patientenproben
AU2004201011B2 (en) * 1999-06-30 2005-12-22 Biomerieux, Inc Method and apparatus for presenting thrombosis and hemostasis assay data
US6484122B1 (en) * 2000-05-16 2002-11-19 Siemens Aktiengesellschaft System and method for evaluating characteristics for suitability in classification
JP5051960B2 (ja) * 2000-06-09 2012-10-17 ビオメリュー・インコーポレイテッド リポタンパク質と急性期タンパク質との複合体を検出し、系の不全または致死のリスクの増加を予測する方法
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
US7003403B1 (en) 2000-06-15 2006-02-21 The United States Of America As Represented By The Department Of Health And Human Services Quantifying gene relatedness via nonlinear prediction of gene
US7107287B2 (en) * 2000-07-27 2006-09-12 Canberra Industries Method, system and storage medium for automated independent technical review
US6743596B1 (en) 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US20030104493A1 (en) * 2001-06-29 2003-06-05 Ortel Thomas L. Method for predicting an increased likelihood of antiphospholipid syndrome in a patient
EP1476752A4 (de) 2002-02-27 2008-02-13 Bio Merieux Inc Verfahren zur diagnose und überwachung von hämostatischer fehlfunktion, einer schweren infektion und dem systematische-entzündungsreaktion-syndrom
US20040039556A1 (en) * 2002-08-22 2004-02-26 Ibex Process Technology, Inc. Filter models for dynamic control of complex processes
JP2005538383A (ja) * 2002-09-10 2005-12-15 プラコア・インコーポレーテッド 血小板機能を監視する方法および装置
BR0316197A (pt) 2002-11-12 2005-09-27 Becton Dickinson Co Kit, perfil biomarcador e método de isolar um biomarcador de resposta de hospedeiro
BR0316232A (pt) 2002-11-12 2005-10-04 Becton Dickinson Co Métodos para determinar o estado de sepsia, para prognosticar o começo de sepsia e para diagnosticar a sìndrome de resposta inflamatória sistêmica em um indivìduo
BRPI0609302A2 (pt) 2005-04-15 2011-10-11 Becton Dickinson Co métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse
JP2008539438A (ja) * 2005-04-25 2008-11-13 プラコア・インコーポレーテッド 血小板の機能を監視するための方法及びデバイス
US20070020764A1 (en) * 2005-07-20 2007-01-25 Miller Kerry L Method for processing chemistry and coagulation test samples in a laboratory workcell
US7815809B2 (en) * 2005-12-13 2010-10-19 Gambro Lundia Ab Method for conductivity calculation in a treatment fluid upstream and downstream a filtration unit in apparatuses for the blood treatment
JP4925703B2 (ja) 2006-03-30 2012-05-09 シスメックス株式会社 血液凝固分析装置
US20100099130A1 (en) * 2006-10-25 2010-04-22 Placor Inc. Methods and devices for monitoring platelet function
WO2009101242A1 (en) * 2008-02-14 2009-08-20 Orion Diagnostica Oy Method for predicting a future property
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
US8046175B2 (en) * 2008-10-13 2011-10-25 Actherm Inc Analytical strip reading apparatus and the analyical strip used therein
JP2012510621A (ja) * 2008-12-05 2012-05-10 紅電醫學科技股▲分▼有限公司 取り外し可能なファームウェアを備えた試験片読取装置
US8645306B2 (en) * 2010-07-02 2014-02-04 Idexx Laboratories, Inc. Automated calibration method and system for a diagnostic analyzer
CN103282873B (zh) * 2010-11-12 2016-08-24 生命科技公司 用于实验室测定确认或验证的系统和方法
JP6211806B2 (ja) * 2013-05-31 2017-10-11 株式会社日立ハイテクノロジーズ 自動分析装置
EP3519828A4 (de) 2016-09-29 2020-06-03 Animantis, LLC Verfahren und vorrichtung zur beurteilung der immunsystemaktivität und der therapeutischen wirksamkeit
JP6873833B2 (ja) * 2017-06-09 2021-05-19 シスメックス株式会社 血液検体の判定方法、血液検体分析装置及びコンピュータプログラム
GB202004047D0 (en) 2020-03-20 2020-05-06 Ainger Phill Point of care sepsis assay device and method

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3307392A (en) * 1964-05-04 1967-03-07 Research Corp Automatic prothrombin timer apparatus and method
US3458287A (en) * 1965-04-29 1969-07-29 Medical Laboratory Automation Method and means of determining endpoint times in blood clotting tests
US3658480A (en) * 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US4047890A (en) * 1973-11-01 1977-09-13 Bio/Data Corporation Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas
SU590665A1 (ru) * 1976-02-11 1978-01-30 Новосибирский государственный медицинский институт Способ исследовани процесса свертывани крови
DE2635081C3 (de) * 1976-08-04 1980-08-07 Bio/Data Corp., Willow Grove, Pa. (V.St.A.) Verfahren und Vorrichtung zur Bestimmung von Blutplasma-Gerinnungsfaktorpegeln
FR2364453A1 (fr) * 1976-09-08 1978-04-07 Lacombe Pierre Dispositif electronique apportant un perfectionnement aux appareils destines a analyser la coagulation sanguine : prothrombinometre citrate-oxalate
US4199748A (en) * 1976-11-01 1980-04-22 Rush-Presbyterian-St. Luke's Medical Center Automated method and apparatus for classification of cells with application to the diagnosis of anemia
JPS5451893A (en) * 1977-09-30 1979-04-24 Sankyo Co Measuring of blood coagulating time
JPS5822703B2 (ja) * 1978-08-30 1983-05-10 三共株式会社 血液凝固測定方法
US4289498A (en) * 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4766083A (en) * 1982-04-04 1988-08-23 Wako Pure Chemical Industries, Ltd. Method for the photometric determination of biological agglutination
SU1076086A1 (ru) * 1982-12-28 1984-02-29 Всесоюзный Научно-Исследовательский И Конструкторский Институт Медицинской Лабораторной Техники Гемокоагулограф
US4705756A (en) * 1983-01-26 1987-11-10 University Of Medicine And Dentistry Of New Jersey Method of determining the existence and/or the monitoring of a pathological condition in a mammal
EP0115459A3 (de) * 1983-01-26 1986-11-20 University Of Medicine And Dentistry Of New Jersey Haematologische Voraussage von Sepsis und anderen erkrankten Zuständen
JPS59203959A (ja) * 1983-05-04 1984-11-19 Toa Medical Electronics Co Ltd 血液凝固時間測定装置
JPH0695095B2 (ja) * 1983-11-25 1994-11-24 株式会社島津製作所 全自動血液分析装置
DE3502878A1 (de) * 1985-01-29 1986-07-31 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung des fibrinolytischen zustands von plasma
JPS61272655A (ja) * 1985-05-28 1986-12-02 Iryo Kogaku Kenkyusho:Kk 血小板凝集能の定量的判定方法
US4965725B1 (en) * 1988-04-08 1996-05-07 Neuromedical Systems Inc Neural network based automated cytological specimen classification system and method
US5156974A (en) * 1988-05-27 1992-10-20 Biodata Corporation Method for determining the fibrinogen level of a blood sample
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
WO1991001383A1 (en) * 1989-07-14 1991-02-07 Michigan State University Method for diagnosing blood clotting disorders
EP0482088B1 (de) * 1989-07-20 1999-03-31 Analytical Control Systems, Inc. Verbesserte kontrollverfahren für stabile blutkoagulation
SU1691741A1 (ru) * 1989-08-25 1991-11-15 Донецкий государственный медицинский институт Способ прогнозировани геморрагических осложнений при травматической болезни
US4998535A (en) * 1989-09-05 1991-03-12 Univ. of Washington New England Medical Center Hospitals, Inc. Thrombolysis predictive instrument
IE904244A1 (en) * 1989-12-01 1991-06-05 Akzo Nv Direct fibrinogen assay
US5169786A (en) * 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
AU663683B2 (en) * 1990-04-17 1995-10-19 Analytical Control Systems, Inc. Coagulation assays and reagents
US5862304A (en) * 1990-05-21 1999-01-19 Board Of Regents, The University Of Texas System Method for predicting the future occurrence of clinically occult or non-existent medical conditions
US5218529A (en) * 1990-07-30 1993-06-08 University Of Georgia Research Foundation, Inc. Neural network system and methods for analysis of organic materials and structures using spectral data
RU2012877C1 (ru) * 1991-04-01 1994-05-15 Белорусский научно-исследовательский институт охраны материнства и детства Способ прогнозирования синдрома дыхательных расстройств у недоношенных новорожденных
DE69122752T2 (de) * 1991-08-02 1997-04-10 Grifols Grupo Sa Verfahren und Vorrichtung zur Bestimmung der Gerinnungszeit von Blut und Plasma
US5716795A (en) * 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
AU2870992A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
JPH05180835A (ja) * 1991-12-27 1993-07-23 S R L:Kk ループスアンチコアグラントの測定方法
JP2934557B2 (ja) * 1992-07-10 1999-08-16 国際試薬株式会社 血液凝固時間測定方法とその装置
JPH0636061A (ja) * 1992-07-21 1994-02-10 Fujitsu Ltd 階層型ニューラルネットワークの学習方式
US5388164A (en) * 1992-08-19 1995-02-07 Olympus Optical Co., Ltd. Method for judging particle agglutination patterns using neural networks
JP3224607B2 (ja) * 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第ｘｉｉｉ因子活性測定方法および該測定用試薬キット
US5369484A (en) * 1992-11-09 1994-11-29 Akzo N.V. Multiple discrete analyzer test apparatus and method
RU2070327C1 (ru) * 1992-12-25 1996-12-10 Безруков Александр Васильевич Устройство для измерения времени свертывания крови
US5344754A (en) * 1993-01-13 1994-09-06 Avocet Medical, Inc. Assay timed by electrical resistance change and test strip
JP2938302B2 (ja) * 1993-02-25 1999-08-23 国際試薬株式会社 血液凝固時間測定方法とその装置
JPH06249857A (ja) * 1993-02-26 1994-09-09 Hitachi Ltd 自動分析装置
RU2061953C1 (ru) * 1993-03-10 1996-06-10 Тюменский государственный медицинский институт МЗ РФ Способ количественного определения общей коагуляционной активности тромбоцитов
CA2168452A1 (en) * 1993-08-16 1995-02-23 Timothy J. Fischer Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
US5473732A (en) * 1993-11-02 1995-12-05 Chang; Hou-Mei H. Relational artificial intelligence system
US5553616A (en) * 1993-11-30 1996-09-10 Florida Institute Of Technology Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator
US5856114A (en) * 1994-03-21 1999-01-05 The University Of Vermont Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings
ATE202633T1 (de) * 1994-04-28 2001-07-15 Dade Behring Inc Kalibrator für prothrombin-zeit-assays
US5504011A (en) * 1994-10-21 1996-04-02 International Technidyne Corporation Portable test apparatus and associated method of performing a blood coagulation test
SE9403833D0 (sv) * 1994-11-08 1994-11-08 Global Hemostasis Inst Mgr Ab Analysförfarande och kit
EP0802986B1 (de) * 1995-01-10 2001-09-19 Hendrik Coenraad Hemker Verfahren zum nachweis des endogenen thrombin-potentials und thrombin substrate zur verwendung in diesen verfahren
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
ATE281238T1 (de) * 1996-03-22 2004-11-15 Dade Behring Inc Kombinierte reagenzaufnahme- und testanordnung
JP3876022B2 (ja) * 1996-09-26 2007-01-31 生化学工業株式会社 血液凝固時間に影響を与える物質の定量方法
EP0841566A1 (de) * 1996-11-11 1998-05-13 Pentapharm A.G. Positivkontrollplasma für den Lupus-Antikoagulant-Nachweiser

Also Published As

Publication number Publication date
JPH11507131A (ja) 1999-06-22
CA2221712A1 (en) 1996-12-19
PT834145E (pt) 2002-03-28
US6269313B1 (en) 2001-07-31
JP3534415B2 (ja) 2004-06-07
EP0834145A1 (de) 1998-04-08
ES2164888T3 (es) 2002-03-01
AU711998B2 (en) 1999-10-28
CA2221712C (en) 2005-01-11
US6101449A (en) 2000-08-08
US20010053959A1 (en) 2001-12-20
US5708591A (en) 1998-01-13
ATE206226T1 (de) 2001-10-15
EP0834145A4 (de) 2000-01-26
KR100462688B1 (ko) 2005-06-13
AU5984796A (en) 1996-12-30
EP0834145B1 (de) 2001-09-26
WO1996041291A1 (en) 1996-12-19
KR19990022407A (ko) 1999-03-25
DK0834145T3 (da) 2002-01-21
DE69615556D1 (de) 2001-10-31

Similar Documents

Publication Publication Date Title
DE69615556D1 (de) Verfahren und apparat zum vorhersagen der präsenz von angeborenen und erworbenen unausgewogenheiten und therapeutischen zuständen
CA2316361A1 (en) A method for predicting an abnormal level of clotting proteins
ATE293840T1 (de) Verfahren und vorrichtung zur vorhersage von plasmaverfahren-oberflächenprofilen
DE59711557D1 (de) Automatisierte Vorrichtung und Verfahren zum Messen und Bestimmen von Molekülen oder Teilen davon
ATE458215T1 (de) Erkennung von fehlern von systemkomponenten in einem kontinuierlichen prozess
DE3851301D1 (de) Apparat und Verfahren zum Messen und/oder Überwachen der Ausnutzung von Fiberoptikleitern.
ATE456271T1 (de) Vorrichtung und verfahren zum testen von produktakzeptanz auf einem drahtlosen gerät
DE3485076D1 (de) Reagenzien, testsaetze und verfahren zum nachweis der kannabinoide.
DE59703703D1 (de) Verfahren zum testen von systemkomponenten eines objektorientierten programms
ATE282208T1 (de) Verfahren und vorrichtung zum vorhersagen von haemostatischer funktionsstörung in patientenproben
DE69601395T2 (de) Verfahren und Vorrichtung zum Messen von Spektren
DE69616640T2 (de) Prüfkopf, Vorrichtung und Verfahren zum Testen von Eiern
SE8701510L (sv) Anordning for bedomning av angfelledrift
ATE268025T1 (de) Vorrichtung und verfahren für leistungs- und fehlerdatenanalyse
ATE313082T1 (de) Verfahren zum betreiben von unterschiedlichen geräten zur durchführung eines prozesses
ATE520514T1 (de) Verfahren und vorrichtung zur energieorientierten optimierung von zyklisch ablaufenden maschinenprozessen
DE69526607T2 (de) Verfahren zum Messen und/oder Normalisieren von Geruchskonzentrationen, und Geruchs- und/oder Feuerdetektionssystem, das eine Ersatzschaltung verwendet
ATE307340T1 (de) Verfahren für die feststellung von asthma suszeptibilität
DE69831773D1 (de) Verfahren zum Prüfen der Reifengleichförmigkeit und Nach-Aufblasvorrichtung für Reifen
ATE196378T1 (de) Vorrichtung und verfahren zum prüfen von münzen
DE59704620D1 (de) Verfahren und vorrichtung zum messen und prüfen von werkstücken
ATE328327T1 (de) Verfahren und apparatur zum präsentieren von daten von thrombose- und haemostaseassays
DK330684A (da) Fremgangsmaade og apparat til afproevning og verificering af fornyelseslogikken for dynamiske mos-lagre
DE59709362D1 (de) Verfahren zum interferometrischen messen von positionen, positionsänderungen und daraus abgeleiteter physikalischer grössen
IL143639A0 (en) Method for determining the activity of a substance using a functional test in vitro

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee